![Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/e24c9982-a714-49bb-bd8b-0da11eab5cc9/gr2_lrg.jpg)
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis - The Lancet Healthy Longevity
![These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-3.jpg&id=546325)
These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial
Dissecting the importance of sex steroids balance for metabolic and reproductive health in men with Klinefelter syndrome: a rand
![These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=546325)
These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial
![These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . TESTOSTERONE gel 1.62% for topical use CIII Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-8.jpg&id=546325)